The Anti-Allergy Medicine Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of anti-allergy medicine has seen robust growth recently, increasing from $38.84 billion in 2024 to a projected $42.25 billion in 2025. This growth represents a compound annual growth rate (CAGR) of 8.8%.
The Anti-Allergy Medicine Global Market is expected to reach $58.47 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.5%.
Download Your Free Sample of the 2025 Anti-Allergy Medicine Market Report and Uncover Key Trends Now!The anti-allergy medicine market covered in this report is segmented –
1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Leukotriene Inhibitors, Mast Cell Stabilizers, Other Drug Classes
2) By Type Of Allergy: Seasonal Allergies, Perennial Allergies, Food Allergies, Skin Allergies, Insect Sting Allergies
3) By Formulation: Tablets, Capsules, Syrups, Nasal Sprays, Eye Drops, Injectables
4) By Application: Online Pharmacy, Hospital, Offline Pharmacy, Clinic, Other Applications
5) By End User: Children, Adults, Geriatric Population, Pregnant Women
The key drivers in the anti-allergy medicine marketare:
• Escalating global rates of allergy incidences
• Growing demand for rapid-response anti-allergy medications
• Increasing elderly population needing allergy treatment
• Expansion of online pharmacies and government initiatives promoting allergy awareness
The key trends in the anti-allergy medicine market are:
• The adoption of advancements in drug delivery systems is an emerging trend.
• There are fresh innovations in non-sedating antihistamines changing the market.
• Developments in personalized allergy treatments are shaping the industry's future.
• The integration of digital health tools for allergy management is a notable trend.
Major companies in the anti-allergy medicine market are:
• Pfizer Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• Bayer AG
• Sanofi S.A.
• AstraZeneca plc
• Novartis AG
• GSK plc
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Perrigo Company plc
• Cipla Limited
• Dr. Reddy's Laboratories
• Lupin Limited
• Zydus Lifesciences Limited
• Takeda Pharmaceutical Company Limited
• Torrent Pharmaceuticals Ltd.
• ALK-Abelló A/S
• Torii Pharmaceutical Co. Ltd.
• Biomay Aktiengesellschaft
• Kaléo Inc.
• Immunomic Therapeutics Inc.
• Circassia Group plc
• Sun Pharmaceutical Industries Ltd.
• Anergis S.A.
• Aravax Pty Ltd.
• DBV Technologies S.A.
• Desentum Oy.
North America was the largest region in the anti-allergy medicine market in 2024